Pharmaceutics, Volume 16, Issue 10
2024 October - 108 articles
Cover Story: Ensuring the prompt and effective induction of mucosal immune responses is a critical area of study in immunology. Nasal vaccines, in particular, offer a promising approach to disease prevention by targeting mucosal tissues. This review delves into the complexities of engineering nasal vaccines with different glycoconjugates aimed at engaging specific C-type lectin receptors, as well as their performance in the nasal mucosa. A thorough analysis of these formulations demonstrated consistent antigen uptake patterns, while further studies confirmed improved immune responses compared to conventional nasal delivery systems. These findings underline the efficacy-boosting potential of targeting CLRs in nasal vaccine development to strengthen immune protection, offering new strategies for more effectively combating respiratory pathogens. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.